Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers

NCT02919696 ·Status: COMPLETED ·Phase: PHASE1

ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL

NCT04603183 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3007113 in Participants With Advanced Cancer

NCT01463631 ·Status: COMPLETED ·Phase: PHASE1

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

NCT04031885 ·Status: TERMINATED ·Phase: PHASE4

A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer

NCT02107703 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer

NCT04032080 ·Status: COMPLETED ·Phase: PHASE2

A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

NCT04752332 ·Status: TERMINATED ·Phase: PHASE3

A Study of LY2875358 in Participants With Advanced Cancer

NCT01287546 ·Status: COMPLETED ·Phase: PHASE1

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

NCT02675231 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

NCT00334802 ·Status: COMPLETED ·Phase: PHASE2

A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer

NCT02778126 ·Status: COMPLETED ·Phase: PHASE1

Real-world Data in Patients With Breast Cancer Treated With Abemaciclib

NCT04985058 ·Status: RECRUITING

A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer

NCT04732598 ·Status: COMPLETED ·Phase: PHASE3

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

NCT05169567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

NCT04707196 ·Status: COMPLETED ·Phase: PHASE4

Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer

NCT00356811 ·Status: COMPLETED ·Phase: PHASE2

Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer

NCT04473040 ·Status: AVAILABLE

A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma

NCT04003896 ·Status: TERMINATED ·Phase: PHASE2

Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate

NCT02142868 ·Status: NO_LONGER_AVAILABLE

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

NCT03979508 ·Status: TERMINATED ·Phase: PHASE2

Adjuvant Palbociclib in Elderly Patients With Breast Cancer

NCT03609047 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer

NCT02613208 ·Status: COMPLETED

A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.

NCT04534283 ·Status: TERMINATED ·Phase: PHASE2

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

NCT00733408 ·Status: COMPLETED ·Phase: PHASE2

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

NCT03099174 ·Status: COMPLETED ·Phase: PHASE1